Deloitte December 18, 2019
How will artificial intelligence (AI) drive the digital transformation of biopharma? At the 2019 Global Financial Times Pharmaceutical and Biotechnology conference in London last month, we launched Intelligent drug discovery: Powered by AI. This report—the second in a series—explores the rise of disruptive AI for drug discovery companies and the challenges and opportunities for biopharma in using AI technologies to help find new, more precise, and targeted treatments.1 This blog highlights the key takeaways from our report.
Accelerating drug discovery
Drug discovery is the process of identifying new medicines for treating or curing disease, which has led to many life-saving and life-enhancing clinical treatments. However, the process has historically been long, expensive, and often unsuccessful, with many unmet needs still...
Today's Sponsors
Today's Sponsor